• Results
  • /
  • Latin America & the Caribbean
  • /
  • Panama



10,900 people currently receiving antiretroviral therapy (2017)

Source: UNDP

Retention on ART 12 months after commencing treatment (2016)

Source: UNAIDS

4,600 deaths averted due to people being on ART between 2006 and 2016

Source: UNAIDS

Project Summary

Despite experiencing some of the fastest economic growth in Latin America and having public health services that cover 90% of the population, Panama has significant inequities in the availability and quality of health services. Although the HIV epidemic is concentrated (0.8% prevalence among general population), prevalence among MSM and transgender is amongst the highest in Central America (currently 14% and 15% respectively). Similarly, over the past 15 years, Panama suffered from above-average TB rates but has experienced a faster rate of decline than the region as a whole. Nonetheless, it persists in leading the region in TB incidence.

The current Global Fund HIV/TB grant supports numerous programmatic interventions related to HIV and TB, as well as joint HIV-TB activities, including prevention, treatment and care, procurement and supply chain management, monitoring and evaluation, removing legal barriers to accessing health services, strengthening community systems, and program management. GF grants have significantly improved the reach and quality of the national disease response contributing to scaled up distribution of condoms and lubricants, HIV tests, and TB laboratory supplies and equipment to modernize diagnostic techniques as well as nonmedical supplies including food, vehicles and building supplies. Community peer promoters have also been trained to assist in active searching for HIV and TB cases to increase detection rates. Before the initial GF TB intervention, DOTS coverage in indigenous comarcas was essentially nonexistent at just 3 percent; through the GF-supported project, coverage expanded to nearly 100 percent in these regions. Other training has focused on programmatic strengthening, such as human resources and equipment maintenance. The current grant also includes civil society strengthening as a goal. This is reflected in the fact that CSOs were involved in the development of the most recent national TB and HIV strategic plans.



1,600 new smear positive TB cases detected and treated

Source: UNDP


HIV positive TB patients on ART (2016)

Source: World Health Organization

TB related mortality

Source: World Health Organization



Maternal mortality

Source: World Health Organization

Infant mortality

Source: World Health Organization




Disease Component





Period 1 (Jan 2016 - Dec 2018)







Overall Grant Rating



  Exceeding expectations


  Meeting expectations




  Inadequate but potential demonstrated




  No rating available